We have previously shown that ICE®/tumor-antigen associated cross-link-experienced healthy donor-derived NK cells are triggered to phenotypic changes boosting proliferation and cytotoxic capacity in response cytokines, such as IL-2 and IL-15 [46]. The gene discussed is IL15; the disease is neoplasm.